1. Home
  2. LEE vs PMVP Comparison

LEE vs PMVP Comparison

Compare LEE & PMVP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lee Enterprises Incorporated

LEE

Lee Enterprises Incorporated

N/A

Current Price

$8.26

Market Cap

160.1M

ML Signal

N/A

Logo PMV Pharmaceuticals Inc.

PMVP

PMV Pharmaceuticals Inc.

N/A

Current Price

$1.39

Market Cap

79.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LEE
PMVP
Founded
1890
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Newspapers/Magazines
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
160.1M
79.5M
IPO Year
2025
2020

Fundamental Metrics

Financial Performance
Metric
LEE
PMVP
Price
$8.26
$1.39
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$5.00
AVG Volume (30 Days)
110.1K
879.6K
Earning Date
05-07-2026
03-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$543,955,000.00
N/A
Revenue This Year
$5.48
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.34
$0.82
52 Week High
$10.88
$1.88

Technical Indicators

Market Signals
Indicator
LEE
PMVP
Relative Strength Index (RSI) 50.18 47.09
Support Level $3.77 $1.37
Resistance Level $9.74 $1.43
Average True Range (ATR) 0.71 0.07
MACD -0.23 -0.03
Stochastic Oscillator 23.59 0.00

Price Performance

Historical Comparison
LEE
PMVP

About LEE Lee Enterprises Incorporated

Lee Enterprises Inc is a local news publication company in the United States. It is a digital-first subscription business providing local markets with valuable, high-quality, trusted, intensely local news, information, advertising, and marketing services. The product portfolio of the company includes digital subscription platforms, daily, weekly, and monthly newspapers, and niche products, all delivering original local news and information as well as national and international news. The products offer digital and print editions, and content and advertising are available in real-time through the websites and mobile apps.

About PMVP PMV Pharmaceuticals Inc.

PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. The key product candidate, rezatapopt, is designed to be an orally available small molecule that structurally corrects the mutant p53 protein with the Y220C mutation. Currently, the product candidates are undergoing preclinical and clinical testing, and company relies on third parties for the manufacture after marketing approvals.

Share on Social Networks: